JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arellano, R.
Right arrow Articles by Lampe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arellano, R.
Right arrow Articles by Lampe, H.
Related Collections
Right arrow Blood
Right arrow Surgery
Right arrow Resuscitation
Right arrow Critical Care

Anesth Analg 2005;100:1846-1853
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000152008.04333.53

GENERAL ARTICLES

A Triple-Blinded Randomized Trial Comparing the Hemostatic Effects of Large-Dose 10% Hydroxyethyl Starch 264/0.45 Versus 5% Albumin During Major Reconstructive Surgery

Ramiro Arellano, MD, MSc, FRCPC, Bing Siang Gan, MD, PhD, FRCSC, FACS, Mary Jane Salpeter, RN, Erik Yeo, MD, PhD, FRCPC, Stuart McCluskey, MD, PhD, FRCPC, Ruxandra Pinto, PhD, Jonathan Irish, MD, MSc, FRCSC, Douglas C. Ross, MD, FRCSC, D. John Doyle, MD, PhD, FRCPC, John Parkin, MD, FRCPC, Dale Brown, MD, FRCSC, Lorne Rotstein, MD, FRCSC, FACS, Ian Witterick, MD, FRCSC, Wayne Matthews, MD, FRCSC, John Yoo, MD, FRCSC, Peter C. Neligan, MD, FRCSC, FACS, Pat Gullane, MD, FRCSC, FACS, and Howard Lampe, MD, FRCSC

Departments of Anesthesia, Surgery, Hematology, Otolaryngology, Biostatistics and Clinical Epidemiology. The Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada and St. Joseph’s Health Centre, University of Western Ontario, London, Ontario, Canada

Address correspondence and reprint requests to Ramiro Arellano, MD, MSc, FRCPC, Department of Anesthesia, Kingston General Hospital, 76 Stuart Street Kingston, Ontario, Canada K7L 2V7. Address e-mail to arel111{at}yahoo.com.

In Canada, hydroxyethyl starch 264/0.45 (HES 264/0.45; molar weight 264 kDa, molar substitution 0.45) has largely replaced albumin as the colloidal fluid of choice for perioperative intravascular volume expansion. The maximum recommended dose of HES 264/0.45 is 28 mL/kg; however, there are no clinical data supporting this limit. In this study we compared the hemostatic effects of HES 264/0.45 versus 5% albumin in doses up to 45 mL/kg over 24 h during major reconstructive head and neck surgery. Fifty patients were randomized to receive HES 264/0.45 or 5% human albumin from the induction of anesthesia until 24 h thereafter. Both albumin and HES 264/0.45 effectively maintained physiologic variables in the perioperative and postoperative periods. The partial thromboplastin time and international normalized ratio were significantly increased in the HES 264/0.45 group compared with the albumin group after infusion of 30 mL/kg and 45 mL/kg (P < 0.05). Factor VIII activity and von Willebrand factor level were significantly reduced in the HES 264/0.45 group compared with the albumin group after infusion of 15 mL/kg, 30 mL/kg, and 45 mL/kg (P < 0.05). Significantly more subjects in the HES 264/0.45 group received allogeneic red blood cell transfusions (P < 0.02). We conclude that HES 264/0.45 infusions >30 mL/kg over 24 h impair coagulation to a greater extent than albumin, possibly leading to more allogeneic transfusions.




This article has been cited by other articles:


Home page
 NEJMHome page
F. M. Brunkhorst, C. Engel, F. Bloos, A. Meier-Hellmann, M. Ragaller, N. Weiler, O. Moerer, M. Gruendling, M. Oppert, S. Grond, et al.
Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis
N. Engl. J. Med., January 10, 2008; 358(2): 125 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. G. Kang, H. J. Ahn, G. S. Kim, T. S. Hahm, J. J. Lee, M. S. Gwak, and S. J. Choi
The Hemostatic Profiles of Patients with Type O and Non-O Blood After Acute Normovolemic Hemodilution with 6% Hydroxyethyl Starch (130/0.4)
Anesth. Analg., December 1, 2006; 103(6): 1543 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 ASH ANNUAL MEETING ABSTRACTSHome page
D. Scarvelis
Aberration of Coagulation Parameters with a Small Dose of Hydroxyethyl Starch in a Patient with Underlying Factor XII Deficiency: A Case Report.
Blood (ASH Annual Meeting Abstracts), November 16, 2006; 108(11): 4058 - 4058.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
A. Shander and D. Moskowitz
Hydroxyethyl starch and risk of bleeding: the missing links.
Anesth. Analg., March 1, 2006; 102(3): 968 - 968.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.